Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.59 USD | -2.65% | -3.92% | -17.80% |
07-01 | HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study | MT |
07-01 | HOOKIPA Pharma Inc. Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.80% | 85.22B | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Insider Sell: Gilead Sciences